These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 3107029

  • 1. The effect of kappa-opioid agonist U-50, 488H on wet-dog shaking behavior induced by hippocampal stimulation in rats.
    Ohno M, Yamamoto T, Araki H, Ueki S.
    Psychopharmacology (Berl); 1987; 91(2):189-92. PubMed ID: 3107029
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of morphine and neuroleptics on wet-dog shaking behavior elicited by hippocampal stimulation in rats.
    Araki H, Aihara H.
    Psychopharmacology (Berl); 1985; 85(3):301-5. PubMed ID: 2860686
    [Abstract] [Full Text] [Related]

  • 6. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
    Wilson JL, Nayanar V, Walker JS.
    Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
    [Abstract] [Full Text] [Related]

  • 7. Further study of kappa opioids on increased urination.
    Leander JD.
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [Abstract] [Full Text] [Related]

  • 8. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
    Yamamoto T, Ohno M, Ueki S.
    Eur J Pharmacol; 1988 Oct 26; 156(1):173-6. PubMed ID: 2850208
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats.
    Kamei J, Tanihara H, Kasuya Y.
    Eur J Pharmacol; 1990 Oct 09; 187(2):281-6. PubMed ID: 2272363
    [Abstract] [Full Text] [Related]

  • 13. Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice.
    Kuzmin AV, Semenova S, Gerrits MA, Zvartau EE, Van Ree JM.
    Eur J Pharmacol; 1997 Mar 05; 321(3):265-71. PubMed ID: 9085036
    [Abstract] [Full Text] [Related]

  • 14. Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist.
    Ukai M, Kameyama T.
    Brain Res; 1985 Jul 01; 337(2):352-6. PubMed ID: 2992682
    [Abstract] [Full Text] [Related]

  • 15. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
    Randich A, Robertson JD, Willingham T.
    Brain Res; 1993 Feb 19; 603(2):186-200. PubMed ID: 8096421
    [Abstract] [Full Text] [Related]

  • 16. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
    Herrero JF, Headley PM.
    Br J Pharmacol; 1991 Sep 19; 104(1):166-70. PubMed ID: 1664760
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA, Burks TF.
    J Pharmacol Exp Ther; 1988 Feb 19; 244(2):456-62. PubMed ID: 2831341
    [Abstract] [Full Text] [Related]

  • 20. Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats.
    Diop L, Rivière PJ, Pascaud X, Dassaud M, Junien JL.
    Eur J Pharmacol; 1994 May 12; 257(1-2):181-7. PubMed ID: 8082700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.